JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home


387	Tue, 7/31/2012, 2:00 PM - 3:50 PM	CC-Room 26A
Statistical Issues in Oncology Clinical Trials: Progression-Free Survival and Overall Survival — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Ying Wan, Janssen Pharmaceuticals R&D
Chair(s): Thian Kheoh, Janssen Pharmaceuticals R&D
2:05 PM	Advanced Application of PFS to Accelerated Oncology Drug Development — Cong Chen, Merck ; Zhiping Sun, Merck
2:25 PM	PFS, OS, and Multi-State Counting Processes — Xiaolong Luo, Celgene Corporation ; Guang Chen, Celgene Corporation ; Zhinuan Yu, Celgene Corporation ; Soo Peter Ouyang, Celgene Corporation
2:45 PM	Multiple Primary Endpoints in Oncology Trials — Bin Yao, Amgen, Inc. ; Ai Li, Amgen, Inc.
3:05 PM	A Model for the Joint Estimation of Interval-Censored Progression Time and Survival — Dianne M Finkelstein, Massachusetts General Hospital/Harvard University ; David A Schoenfeld, Harvard Medical School
3:25 PM	Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.